27 Resources


<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
Strengthening non-communicable disease care in all-hazards emergencies
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

The Lancet

Strengthening non-communicable disease care in all-hazards emergencies

Article

16 Sep 2025

People with non-communicable diseases (NCDs) are particularly vulnerable to health service disruptions resulting from conflicts, natural disasters, and major disease outbreaks. The 2018 Political Declaration of the 3rd UN High-Level Meeting of the General Assembly on the Prevention and Control of NCDs called for the strengthening of health system resilience to withstand emergencies due to all haza...

Access



<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
Metrics for diplomats: is mortality from non-communicable diseases increasing or decreasing?
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

The Lancet

Metrics for diplomats: is mortality from non-communicable diseases increasing or decreasing?

Article

03 Jul 2025

Negotiations are ongoing in New York to agree the latest UN political declaration on non-communicable diseases (NCDs) and mental health.1 With 5 years left to deliver the 2030 Sustainable Development Agenda, diplomats will be developing a roadmap to get the world as close as possible to achieving Sustainable Development Goal (SDG) target 3.4.1, which is to reduce premature mortality (between the a...

Access



<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
Acute pulmonary embolism in children and adolescents in the USA (2016 and 2019): a nationwide retrospective cohort study
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

International Society on Thrombosis and Haemostasis

Acute pulmonary embolism in children and adolescents in the USA (2016 and 2019): a nationwide retrospective cohort study

Publication

24 May 2025

A new study published in The Lancet Respiratory Medicine provides critical insights into the incidence and outcomes of acute pulmonary embolism (PE) among children and adolescents, filling a longstanding gap in epidemiological data on this serious condition. The paper, which includes several authors from the ISTH global community, analyzed nationwide U.S. hospital admission data from 2016 and 2019...

Access



<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
Rising to the challenge: Five takeaways from the International Meeting on type 1 diabetes 
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Diabetes Foundation

Rising to the challenge: Five takeaways from the International Meeting on type 1 diabetes

Article

18 Feb 2025

In a groundbreaking conference, international leaders in type 1 diabetes care exchanged knowledge, strategies, and visions for the future. Here are key takeaways from the discussions that are set to reshape type 1 diabetes (T1D) care and patient empowerment.&nbsp;While facing a rising tide of non-communicable diseases (NCDs), type 1 diabetes (T1D) represents a special challenge particularly in low...

Access



<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
Redefining obesity: advancing care for better lives
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

The Lancet Diabetes & Endocrinology

Redefining obesity: advancing care for better lives

Publication

06 Feb 2025

The Lancet Diabetes &amp; Endocrinology Commission introduces a groundbreaking redefinition of obesity, distinguishing between clinical obesity (a chronic disease) and preclinical obesity (a risk factor). This new approach moves beyond BMI, paving the way for more precise diagnosis, treatment, and global health policy updates.

Access



<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
Acceptability and perceptions of personalised risk-based cancer screening among health-care professionals and the general public: a systematic review and meta-analysis
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

The Lancet Public Health

Acceptability and perceptions of personalised risk-based cancer screening among health-care professionals and the general public: a systematic review and meta-analysis

Article

01 Feb 2025

This systematic review and meta-analysis examines the acceptability and perceptions of personalised risk-based screening (PRBS) for breast, cervical, colorectal, lung, and prostate cancer among the general public and health-care professionals.The study synthesises data from 63 research articles published between 2010 and 2024, with findings indicating that PRBS is generally acceptable to both the...

Access



<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

The Lancet

Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants

Article

01 Dec 2024

Diabetes can be detected at the primary health-care level, and effective treatments lower the risk of complications. There are insufficient data on the coverage of treatment for diabetes and how it has changed. We estimated trends from 1990 to 2022 in diabetes prevalence and treatment for 200 countries and territories.

Access



<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
Early-life prevention of non-communicable diseases
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

The Lancet

Early-life prevention of non-communicable diseases

Report

25 Oct 2024

Report advocates for minimizing &nbsp;in-utero and childhood risks for NCDs as an imperitive for reducing poverty and gendered inequalities.

Access



<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
A discussion about the Lancet Commission on Women and Cancer - Dr Ophira Ginsburg and Dr Carinna Hockham
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

The George Institute for Global Health

A discussion about the Lancet Commission on Women and Cancer - Dr Ophira Ginsburg and Dr Carinna Hockham

Dialogue

25 Oct 2024

This episode features a discussion with Dr Ophira Ginsburg and Dr Carinna Hockham about the Lancet Commission on Women and Cancer, currently underway. The Commission is exploring the relationship between gender, power and cancer, and is taking an intentionally broad, intersectional feminist approach to its investigation. Despite the Commission’s title the work is inclusive of all genders insofar...

Access



<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
NCDs: Can implementation research change the game for policy and practice?    
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

Global Alliance for Chronic Diseases (GACD), The Lancet

NCDs: Can implementation research change the game for policy and practice?

Publication

10 Sep 2024

Non-communicable diseases (NCDs) account for 74% of all deaths and 86% of premature deaths in low-income and middle-income countries (LMICs).&nbsp;Yet, the world is far from meeting the globally agreed targets for their control.&nbsp;Even in this unprecedented era for discovery of new therapies for NCDs, the ability to equitably deliver both old and new interventions is lagging. &nbsp; WHO h...

Access



<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

Medicines Patent Pool (MPP), The Lancet Global Health Commissions

Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities

Publication

19 Aug 2024

This paper focuses on expanding access to biotherapeutics in low- and middle-income countries (LMICs) through public health non-exclusive voluntary intellectual property licensing.The key elements identified as relevant to support access to affordable biosimilars in LMICs through licensing include:Prioritising potential biotherapeutic targets according to their potential for public health impactSu...

Access



<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
Commentary: A plan for accelerated action on obesity
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

The Lancet

Commentary: A plan for accelerated action on obesity

Article

04 Aug 2023

Halting the rise in obesity among children, adolescents, and adults is essential to combat the growing burden of non-communicable diseases and to improve nutrition, health, and wellbeing for all. Failing to do so threatens progress towards reducing premature mortality from non-communicable diseases by 30%—a key target of the 2030 Sustainable Development Goals. &nbsp; No country is on track...

Access

Pagination